From major journals, first or last author from the Institute for Cancer Research Thulin MH, Ramberg H, Nielsen HK, Grytli HH, Sivanesan S, Pandya AD, Seip K, Andressen KW, Linder A, Øijordsbakken M, Poutanen M, Katz B, Halvorsen B, Mælandsmo GM, Taskén KA (2025) Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis J Transl Med, 23 (1), 672 DOI 10.1186/s12967-025-06644-7, PubMed 40528241 Singh R, Kyte JA (2025) STEAP1: a promising target in prostate cancer therapy Trends Cancer (in press) DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692 Røssevold AH, Tekpli X, Lingjærde OC, Russnes HG, Vallon-Christersson J, Borgen E, Lømo J, Garred Ø, Dorraji E, Kristensen VN, Naume B, Kyte JA (2025) High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis Commun Med (Lond), 5 (1), 234 DOI 10.1038/s43856-025-00865-z, PubMed 40523912 More selected publications
Most recent publications Thulin MH, Ramberg H, Nielsen HK, Grytli HH, Sivanesan S, Pandya AD, Seip K, Andressen KW, Linder A, Øijordsbakken M, Poutanen M, Katz B, Halvorsen B, Mælandsmo GM, Taskén KA (2025) Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis J Transl Med, 23 (1), 672 DOI 10.1186/s12967-025-06644-7, PubMed 40528241 Røssevold AH, Tekpli X, Lingjærde OC, Russnes HG, Vallon-Christersson J, Borgen E, Lømo J, Garred Ø, Dorraji E, Kristensen VN, Naume B, Kyte JA (2025) High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis Commun Med (Lond), 5 (1), 234 DOI 10.1038/s43856-025-00865-z, PubMed 40523912 Singh R, Kyte JA (2025) STEAP1: a promising target in prostate cancer therapy Trends Cancer (in press) DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692 More publications Annual summary of publications
